Home›Stock Screener›Zim Laboratories›Quarterly Results

Zim Laboratories Quarterly Results

Latest Quarter Net Profit
₹4 Cr
QMar 2026
Quarterly Results

Zim Laboratories quarterly results. In Mar 2026, Zim Laboratories (ZIMLAB) reported revenue ₹111 Cr and net profit ₹4 Cr — revenue +0.9% YoY. Check Zim Laboratories networth to track the company's total market size over time.

ZIMLAB Quarterly Results — Revenue, Profit & EPS Highlights

Zim Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit ZIMLAB share price screener.

  • Revenue of ₹111 Cr in Mar 2026 (+16.8% vs Jun 2026, +0.9% vs Mar 2025)
  • Net Profit of ₹4 Cr in Mar 2026 (+200.0% vs Jun 2026, -20.0% vs Mar 2025)
  • EBITDA of ₹13 Cr in Mar 2026 (+333.3% vs Jun 2026)
  • Operating Margin of 7.0% in Mar 2026 (+4.0pp vs Jun 2026)
  • Earnings Per Share of ₹0.76 in Mar 2026 (+201.3% vs Jun 2026)

Zim Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ZIMLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 111 95 91 110 73 16.8% 0.9%
Net Profit (₹ Cr) 4 -4 0 5 -2 - -
EBITDA (₹ Cr) 13 3 8 16 6 - -
EPS (₹) 0.76 -0.75 -0.09 1.01 -0.38 - -
Operating Margin (%) 7.0% 3.0% 6.0% 13.0% 6.0% - -

ZIMLAB Share Price Trend — 1-Year Movement Across Quarterly Results

Zim Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Review ZIMLAB PE ratio trends to evaluate earnings-based valuation against sector peers.

Profitability Ratios

Profit Margin 3.6%
EBITDA Margin 11.7%
Operating Margin 7.0%
ROE (Annual) 5.4%

Balance Sheet Highlights

Total Assets ₹539 Cr
Total Equity ₹296 Cr
Current Assets ₹276 Cr
Current Liabilities ₹53 Cr

Cash Flow Analysis

Operating Cash Flow ₹50 Cr
Investing Cash Flow ₹-55 Cr
Financing Cash Flow ₹28 Cr
Net Cash Flow ₹23 Cr

Current Market Data

Current Price ₹137.10
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 110
Sept 2025 91
Jun 2026 95
Mar 2026 111

Net Profit Trend (₹ Cr)

Mar 2025 5
Sept 2025 0
Jun 2026 -4
Mar 2026 4

Operating Margin Trend (%)

Mar 2025 13.0%
Sept 2025 6.0%
Jun 2026 3.0%
Mar 2026 7.0%

ZIMLAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Zim Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Laurus Labs
Mar 2026 		₹109,629.35 Cr 1971.4 1,823 282 -10.5% - 15.5% 381.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores